Get the Stockscreener App
0.89
4.13%
-0.0383
Neuroone Medical Technologies Corp stock is traded at $0.89, with a volume of 53,641.
It is down -4.13% in the last 24 hours and down -7.14% over the past month.
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
See More
Previous Close:
$0.9283
Open:
$0.936
24h Volume:
53,641
Relative Volume:
0.90
Market Cap:
$28.86M
Revenue:
$2.82M
Net Income/Loss:
$-13.47M
P/E Ratio:
-1.459
EPS:
-0.61
Net Cash Flow:
$-13.61M
1W Performance:
-8.25%
1M Performance:
-7.14%
6M Performance:
-23.93%
1Y Performance:
+0.91%
1-Day Range:
$0.89
$0.952
1-Week Range:
$0.89
$1.0399
52-Week Range:
$0.602
$2.00
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Name
Neuroone Medical Technologies Corp
Sector
Industry
Phone
(952) 426-1383
Address
7599 ANAGRAM DR, EDEN PRAIRIE
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-29-22 | Downgrade | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Stock (NMTC) Latest News
NeuroOne agree $3m partnership with Zimmer Biomet - Yahoo! Voices
NeuroOne expands agreement with Zimmer Biomet for commercialisation of OneRF ablation system - NeuroNews International
Zimmer licenses NeuroOne brain ablation system - Yahoo Finance
NeuroOne Expands OneRF Distribution Deal with Zimmer Biomet - MPO-mag
NeuroOne expands distribution with Zimmer Biomet - Investing.com
NeuroOne Medical Technologies adjusts executive severance terms - Investing.com
NeuroOne touts breakthrough case with neuroablation system - Mass Device
Does NeuroOne Medical Technologies Corp (NMTC) offer a good opportunity for investors? - SETE News
Examining NeuroOne Medical Technologies Corp (NMTC) more closely is necessary - US Post News
NeuroOne Medical Technologies (NASDAQ:NMTC) Issues Quarterly Earnings Results - Defense World
Earnings call: NeuroOne reports progress in Q3 with OneRF system launch - Investing.com Australia
NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update - StockTitan
NeuroOne announces $2.65M equity financing, $3.0M credit facility - Medical Buyer
NeuroOne secures $5.65 million to advance OneRF system - Investing.com
Neuroone stock hits 52-week low at $0.63 amid market challenges - Investing.com
NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility - StockTitan
NeuroOne Medical Technologies (NASDAQ:NMTC) Stock Price Down 2.3% - Defense World
NeuroOne faces Nasdaq delisting over share price woe - Investing.com
NeuroOne Medical Technologies Corp (NMTC) Stock: A Year of Stock Market Dynamics - The InvestChronicle
NeuroOne announces first-in-human ablations completed with OneRF system - NeuroNews International
First patient treated with NeuroOne brain ablation system - Medical Device Network
NeuroOne gains new CMS code for brain ablation system By Investing.com - Investing.com
NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation - GlobeNewswire Inc.
NeuroOne Medical Technologies Corp (NMTC) Stock: A Year of Market Fluctuations - The InvestChronicle
Kintara Therapeutics restructures share designations By Investing.com - Investing.com
NeuroOne Medical Technologies (NASDAQ:NMTC) & SeaStar Medical (NASDAQ:ICU) Head-To-Head Analysis - Defense World
NeuroOne executive sells over $1900 in company stock - Investing.com India
NeuroOne executive sells over $1,900 in company stock By Investing.com - Investing.com
NeuroOne business development director sells shares worth over $22k By Investing.com - Investing.com Australia
NeuroOne business development director sells shares worth over $22k - Investing.com India
NeuroOne Medical Technologies (NASDAQ:NMTC) Trading 2.3% Higher - Defense World
Closing Figures: NeuroOne Medical Technologies Corp (NMTC)'s Negative Finish at 0.95, Down -4.05 – DWinneX - The Dwinnex
Insider Buyers Lose US$36k As NeuroOne Medical Technologies Sheds US$3.0m - Simply Wall St
Sales And Marketing Software Stocks Q1 Teardown: Sprout Social (NASDAQ:SPT) Vs The Rest - Barchart
Can NeuroOne Medical Technologies Corp Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle
xAI, Elon Musk's Artificial Intelligence (AI) Company, Has Spectacular News for Nvidia Stock Investors - Barchart
YNR Syndicate Celebrates Remarkable Growth Milestones - Barchart
Massive News For Palantir Stock Investors - Barchart
NeuroOne Delivers on Its Promise with the OneRF™ Ablation System Launch - Barchart
Q1 Rundown: Texas Instruments (NASDAQ:TXN) Vs Other Analog Semiconductors Stocks - Barchart
Stocks Settle Mixed as Indexes Consolidate Below Record Highs - Barchart
Earnings call: NeuroOne reports growth and strategic progress in Q2 - Investing.com South Africa
Earnings call: NeuroOne reports growth and strategic progress in Q2 By Investing.com - Investing.com
NeuroOne ® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update - Investing.com India
Stocks Climb on Lower Bond Yields and Positive Corporate News - Barchart
NeuroOne Medical Technologies (NMTC) to Release Earnings on Tuesday - Defense World
NeuroOne ® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14 - Investing.com India
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14 - ForexTV.com
Financial Analysis: NeuroOne Medical Technologies Corp (NMTC)'s Ratios Unveil Key Insights – DWinneX - The Dwinnex
Stocks Waver on Higher Bond Yields and Mixed Corporate Earnings - Barchart
Favourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired Stock - Yahoo Canada Finance
Neuroone Medical Technologies Corp Stock (NMTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neuroone Medical Technologies Corp Stock (NMTC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Christianson Mark | Business Development Director |
Jun 05 '24 |
Sale |
0.88 |
25,800 |
22,663 |
297,224 |
| Christianson Mark | Business Development Director |
Dec 27 '23 |
Sale |
1.46 |
31,445 |
45,859 |
300,594 |
| Christianson Mark | Business Development Director |
Dec 26 '23 |
Sale |
1.35 |
6,848 |
9,269 |
332,039 |
| Volker Christopher | Chief Operating Officer |
Dec 21 '23 |
Buy |
1.40 |
75,000 |
105,000 |
75,000 |
| Christianson Mark | Business Development Director |
Dec 21 '23 |
Sale |
1.40 |
9,907 |
13,870 |
340,687 |
| Christianson Mark | Business Development Director |
Dec 22 '23 |
Sale |
1.40 |
1,800 |
2,520 |
338,887 |
0.47%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):